We are live on ! Find out more
SRGA

Surgalign Holdings, Inc. Common Stock

Delisted

SRGA was delisted on the 30th of June, 2023.

88 hedge funds and large institutions have $145M invested in Surgalign Holdings, Inc. Common Stock in 2020 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 31 increasing their positions, 20 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

87% more capital invested

Capital invested by funds: $77.8M → $145M (+$67.4M)

55% more repeat investments, than reductions

Existing positions increased: 31 | Existing positions reduced: 20

38% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 13

6% more funds holding

Funds holding: 8388 (+5)

0.38% less ownership

Funds ownership: 61.62%61.24% (-0.38%)

33% less funds holding in top 10

Funds holding in top 10: 32 (-1)

66% less call options, than puts

Call options by funds: $30K | Put options by funds: $87K

Holders
88
Holders Change
+5
Holders Change %
+6.02%
% of All Funds
1.8%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.04%
New
18
Increased
31
Reduced
20
Closed
13
Calls
$30K
Puts
$87K
Net Calls
-$57K
Net Calls Change
-$77K

SRGA Hedge Fund Activity: Q2 2020 in Review

88 of the 4,889 institutional investors tracked by Wall St. Rank reported a position in Surgalign Holdings, Inc. Common Stock (SRGA) for Q2 2020, worth a combined $145M — up 87% from $77.8M a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new SRGA positions and 13 closed out — a net gain of 5 holders — while 31 added to existing stakes and 20 trimmed.

The largest buyer was Krensavage Asset Management, adding an estimated $4.53M. The largest seller was Kopp Family Office, exiting entirely with an estimated $6.17M sold.

  • 88 institutional investors held Surgalign Holdings, Inc. Common Stock (SRGA) as of Q2 2020, up from 83 in Q1 2020.
  • Funds reported $145M of Surgalign Holdings, Inc. Common Stock stock for Q2 2020, up 87% quarter-over-quarter.
  • 18 funds opened new Surgalign Holdings, Inc. Common Stock positions in Q2 2020 and 13 closed out, a net change of +5 holders.
  • The largest Surgalign Holdings, Inc. Common Stock buyer in Q2 2020 was Krensavage Asset Management, an estimated $4.53M added.
  • The largest Surgalign Holdings, Inc. Common Stock seller in Q2 2020 was Kopp Family Office, an estimated $6.17M sold.

Based on aggregated 13F filings for Q2 2020.